The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Tivman,
I agree that BELL is a great investment and has promise. I just do not want a repitition of the damage caused by the last listing. If I am upset that they sell a part of the BELL holding - I can buy it myself as its a listed asset. Hence I dont like the idea of a capital raise at a super discount to enable us to maintain a holding I can get direct should i wish to.
100% agree the 4 companies are superb. Its just in raising in the current market, I am not sure the pain is worth the benefit.
I did top up this morning though - so clearly I am still a firm believer in this stock, its investments and by proxy, the ability of this board to get on the right companies - so I am griping a detail, not the whole chebang.
AtB
NtD
Afternoon
I think the fact the company didn’t sell any Bell shares instead of the placing shows confidence on where they think bell is going, i for one am glad as i think bell has a great future and it could become a take over target at some point
I agree it should have been done higher, but getting any placing away in this market is very difficult
We have a 4 company main portfolio and in my view all look like they could be company makers
The ceo has got us to this point and i am confident its just the start
Also I wouldn’t be surprised to see further companies join the portfolio
All imho
All the best
Staggering drop . When they raised at lower than the previous placing price it was completely idiotic. It has caused huge damage to shareholders. Like you say It's a good time to buy but I think many will be p off with the management right now. CEO should be replaced.
I am sorely tempted to top up here. Its only the fear of further capital raises that stops me. Microsalt appears to be such a solid good investment at the minute. Personally I think that if TEK stated that any further cash call requirements were to be met by selling of BELL stock in the short term- we would see a big lift in this price.
I am very surprised to see 20p. Probably pushes me to the buyside today.
Morning all
Great RNS from Bell. Very important to TEK that BELL progesses as it's doing. It undermines the whole TEK business model and also fundamental to value.
Hard times with regard to the market but AIM stocks generally recover quickly when they upturn comes. Hopefully sooner rather than later
In my other group (telegram), we think it’s an ii selling out to cover their losses. Just hang on peeps…
Puma , rubbish times and not going to improve massively in the short term imho, for those of us that truly believe in the strategy this will pay off I'm sure at some point although confidence has taken a huge hit currently, I'm not going to lie I'm on the fence between buying more and selling half and staking in Bell ???
Heard that Clifford cancelled because of US legislation regarding the Lucyd IPO, well that's not happening for a while so why not get something organised as the daily drops is getting torturous and from a LTH looking in they don't seem to give a tos s about the price dropping 40%. Rant over
Bell is definitely going places and at a great price currently.
I’m surprised Tek don’t make more of the Bell PR through their own routes ie RNS… etc as they still hold a large chunk and Bell’s performance influences Tek SP.
Great news for Belluscura and for TEK market just keep ignoring good news madness in my view. I think Belluscura will be worth more than current market cap by end of the year
Belluscura PLC
(“Belluscura” or the “Company”)
Belluscura Launches Direct to Consumer Sales and Distribution Plan
New Direct to Consumer and Partnership Distributor Plan expected to increase revenue and gross profits
LONDON, U.K. AND PLANO, TX, U.S. (30 June 2022). Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that it has commenced selling its X-PLOR oxygen concentrators direct to consumers (“DTC”) from the following website: www.xploroxygen.com.
The Company has also started a new partnership distribution programme directed at increasing the availability of portable oxygen concentrators to small, local durable medical equipment providers who are experiencing considerable delays in the wait for portable concentrators. Both initiatives are expected to significantly expand our distribution network across the US and to increase revenue and profits. A brochure containing information on the X-PLOR oxygen concentrator can be found here http://www.rns-pdf.londonstockexchange.com/rns/7145Q_1-2022-6-29.pdf.
Robert Rauker, CEO of Belluscura plc, said: "Selling our products direct to consumers allow us to generate higher revenue and increased profits over the longer term. In addition, our new Partnership Distribution Plan is directed at smaller distributors, further expanding our distribution network throughout the US.”
Adam Reynolds, Chairman of Belluscura plc, said “Both the launch of direct to consumers sales along with making our product available to the hundreds of smaller, local supplemental oxygen providers, creates significant opportunities for Belluscura.”